HOME › DRUGS › LAZERTINIB MESYLATE
ACTIVE SUBSTANCE / INN

LAZERTINIB MESYLATE

Brand name(s): LAZCLUZE
FDA LISTED
PRESCRIPTION
NDA219008
ACTIVE SUBSTANCE
Lazertinib Mesylate
REGULATORS
FDA
SPONSORS / MAH
JANSSEN BIOTECH
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LAZCLUZENDA219008JANSSEN BIOTECHPrescription

FULL INTELLIGENCE ON LAZERTINIB MESYLATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →